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ABSTRACT: Androgens drive male secondary sexual differentia-
tion and maturation. Mutations in the androgen receptor (AR) gene
cause a broad spectrum of abnormal phenotypes in humans, ranging
from mild through partial to complete androgen insensitivity. We
have analyzed the AR gene by using denaturing high-performance
liquid chromatography (DHPLC) and direct sequencing and have
studied gonads histologically in a familial case of complete androgen
insensitivity syndrome. Sequence analysis of the AR gene showed
a novel C2578T missense mutation, resulting in the replacement of
a highly conserved leucine residue with phenylalanine (L859F) in
ligand-binding domain of the receptor. The residue L859, located in
helix 10 of the androgen receptor, plays a significant role in overall
architecture of ligand-binding pocket. The mutation was absent from
the father, normal brother of the patients, and 100 normal males
recruited in this study as controls. The inheritance of the mutation in
the family clearly shows that C2578T is the underlying mutation for
the eventual phenotype in the patients. Histology of patient’s gonads
showed Leydig cell hyperplasia, with a few or no spermatogonium. It
is thought that AR gene mutations result in hormonal imbalance,
resulting in the high levels of luteinizing hormone (LH) and ultimately
Leydig cell hyperplasia or tumor formation. In the present study, we
have reported a rare familial case of Leydig cell hyperplasia despite
consistently normal LH levels. The finding will help in giving
counseling to this family and prevent the transmission of the mutated
X chromosome to the coming generations.
Key words: Androgens, androgen receptor gene.
J Androl 2006;27:510–516
Upon testes differentiation, androgens drive malesecondary sexual differentiation and maturation.
For normal male sexual differentiation, 2 main
androgens—testosterone (T) and dihydrotestosterone
(DHT)—and a functional androgen receptor (AR) gene
are required. Both these androgens complex with the
same receptor for their action but confer different
biological messages. The receptor-T complex signals
differentiation of Wolffian ducts during embryonic life,
regulation of secretion of luteinizing hormone (LH) by
hypothalamic-pituitary axis, and spermatogenesis. The
receptor-DHT complex promotes development of exter-
nal genitalia and prostate gland during embryogenesis
and is also responsible for the changes that occur at
puberty in males (Haqq and Donahoe, 1998).
AR gene mapped to Xq11.2-q12 encodes a protein
with 919 amino acids. AR protein has a domain
organization consisting of a N-terminal domain or
transactivation domain, a DNA-binding domain, and
a ligand-binding domain (LBD). In addition to ligand
binding, LBD is also involved in nuclear localization,
receptor dimerization, and interaction with other
proteins (Brinkmann et al, 1989). Mutations in the AR
gene are known to cause varying levels of androgen
insensitivity syndrome (AIS). Mild AIS (MAIS) is
characterized by undermasculinization (Tsukada et al,
1994) or infertility in otherwise normal males (Wang et
al, 1998). In partial AIS (PAIS), several different
phenotypes are evident, ranging from predominantly
female phenotype to ambiguous genitalia or predomi-
nantly male phenotype with micropenis, perineal hypo-
spadias, or cryptorchidism (Quigley et al, 1995).
Complete AIS (CAIS) is characterized by female
external genitalia usually with small labial folds, a short
blind ending vagina, absence of Wolffian duct–derived
structures and prostate, breast development, and scanty
or absent pubic and axillary hairs.
AIS patients are at a higher risk of developing
gonadal tumors. Seminomas are the most common type
of tumors in these patients. Other malignancies such as
Sertoli cell tumors and Leydig cell tumors are rare. We
report a novel mutation in the AR gene resulting in
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complete androgen insensitivity and Leydig cell hyper-
plasia in 3 patients within a family.
Materials and Methods
Subjects and Clinical History
The family belonged to a suburban area of Hyderabad,
Andhra Pradesh, India. The proband (individual II-3 in
Figure 1A) did not attain menarche up to the age of 20 years
and hence approached the reproductive center of MNR
Medical College Hospital, Medak, Andhra Pradesh, India.
The parents (I-1 and I-2) had no complaints regarding
reproduction. Upon recording the family history, it was found
that 2 of the proband’s siblings (II-5 and II-6) also did not
attain menarche up to the age of 18 years and 16 years,
respectively. A team of highly qualified clinicians carried out
clinical evaluation of the subjects. Physical examination of
these patients revealed typical female phenotype with female
external genitalia, a short blind ending vagina, breast de-
velopment, and scanty axillary and pubic hairs. Real-time
ultrasonography of the pelvis showed nondevelopment of
Wolffian duct–derived structures, well-distended urinary
bladder with no calculi and postvoid residue, no uterus, and
mass lesions in the pelvis. The patients had 1 apparently
normal brother (II-4) and 1 fertile sister (II-2); the later
attained puberty at the age of 13 years with normal feminine
development. She married an apparently normal man and
delivered a child with 46,XY karyotype, female external
Figure 1. (A) Pedigree of the family with complete androgen insensitivity syndrome (CAIS) and the electropherogram showing the mutations.
Individuals with CAIS have been designated by black circles. The sequence electropherogram of the androgen receptor gene is shown below.
The proband (II-3) (shown by arrow) possessed the mutant allele ‘‘T’’ (highlighted with arrow) at the nucleotide position 3693 (base position in
mRNA). Similar mutation is also seen in all the individuals with CAIS (II-5, II-6, and III-1). Both the fertile females in this pedigree (I-2 and II-2)
possessed the heterozygous allele C/T, whereas all 3 males (I-1, II-1, and II-4) possessed the wild-type allele ‘‘C.’’ (B) Clinical picture of
individual with CAIS. Clinical picture of 2-year-old child with CAIS (III-1) shows female external genitalia with small labial folds and no fusion of
labia, characteristic features of CAIS.
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genitalia having small labial folds and a blind ending vagina,
characteristic of CAIS (Figure 1B). Blood samples of all the
family members were collected with their informed written
consent and were subjected to endocrinological, cytogenetic,
and molecular analysis. Gonads of the patients (II-3 and II-5)
were surgically removed because of the risk of cancer and were
subjected to histological examination. This study was ap-
proved by the institutional ethical committee.
Hormone Assays
Serum levels of T, follicle-stimulating hormone (FSH), and LH
were measured by radioimmunoassays for the proband and
the affected siblings. The hormone levels were periodically
measured after every 7 days, and an average of the 3 readings
was taken for further considerations.
Cytogenetic Analysis
Peripheral blood lymphocyte cultures were set up in duplicate
for all the family members in 5-mL culture vials with Roswell
Park Memorial Institute media supplemented with 10% fetal calf
serum. Cells were grown in the presence of penicillin-strepto-
mycin-gentamycin. Phytohemagglutinin was added to stimulate
cell division. Dividing cells were arrested at metaphase stage with
colchicin and fixed in methanol and acetic acid (3:1). Fixed cells
were dropped onto glass slides and allowed to air dry.
Chromosomes were G-banded by treating the preparations with
trypsin followed by staining with Giemsa.
Histological Studies
Gonadal tissue of the proband and 1 of the affected siblings
(II-5) was fixed with 10% buffered neutral formalin solution at
room temperature for 7 days. Tissue was dehydrated with
isopropanol, cleared with xylene at room temperature, and
impregnated with paraffin wax at 58uC. Tissue embedded in
paraffin wax was cut into 4-mm thick sections with a Lei-
caRM2135 microtome (Leica, Germany). The sections were
directly taken on egg albumin–coated glass slides and kept at
60uC for 1 hour. Slides were dewaxed with xylene and stained
with hematoxylin followed by eosin. After staining, slides were
mounted with dipthyline xylene and observed with an
Axioplan imaging system (Zieman, Zeiss, Germany). Images
were captured at different magnifications.
Denaturing High-Performance Liquid Chromatography
and DNA Sequence Analysis
DNA was extracted from peripheral blood samples of all the
family members and controls by using a protocol described
elsewhere (Thangaraj et al, 2002). Polymerase chain reaction
(PCR) primers for the AR gene were taken from our earlier
study (Singh et al, 2006). Eleven pairs of primers amplified all
the exons of the AR gene including the exon-intron splice
junctions. The 10-mL PCR reaction mixture included 1.0 mL
PCR buffer (10X), 1.0 mL MgCl2 (25 mM), 0.8 mL deoxy
nucleotide tri-phosphates (10 mM), 0.5 pM of each primer, 1
unit of AmpliTaq Gold DNA polymerase (Applied Biosys-
tems, Foster City, Calif ), and 20 ng of genomic DNA. PCR
conditions for exon 7 consisted of initial denaturation at 94uC
for 12 minutes followed by 30 cycles of denaturation at 94uC
for 45 seconds, annealing at 58uC for 45 seconds, and
extension at 72uC for 1 minute, with a final extension at
72uC for 10 minutes.
Amplicons of all coding regions of AR gene of the patients,
controls, and both mixed were subjected to denaturing high-
performance liquid chromatography (DHPLC) analysis. The
optimum oven temperature for heteroduplex separation was
selected from the melting profile of the amplicon. After
denaturation and gradual annealing (0.1uC/min) of PCR
product, DHPLC was performed by using the WAVE nucleic
acid fragment analysis system (Transgenomics Inc, Omaha,
Neb). The column was given an equilibration run with buffer B
(0.1 mM TEAA, 25% vol/vol acetonitrile) before injection of
the sample. Aliquots of 8 mL PCR product were loaded on
a preheated C18 reverse phase column based on polystyrene-
divinyl benzene particles. DNA was eluted from the column by
a linear acetonitrile gradient in 0.1 mM triethylamine acetate
buffer (TEAA), pH 7.0, at a constant flow rate of 1.5 mL/min
at 58uC. The gradient was formed by mixing buffer A (0.1 mM
TEAA) and buffer B. Elution of DNA was detected by
ultraviolet absorbance at 260 nm. To confirm the mutation,
PCR product of exon 7 was directly sequenced by using
dideoxy chain terminator cycle sequencing protocol (BigDye
V3.1, Foster City, Calif ) (Thangaraj et al, 2003) on 3700 DNA
analyzer (Applied Biosystems). Later, all the remaining exons
of the AR gene were directly sequenced to confirm absence of
any other mutation in the gene.
Results
Hormone Levels
The proband and 2 siblings tested were found to have T
levels slightly elevated: 670–710 ng/dL (normal male
range 437–707 ng/dL). Levels of FSH and LH were
within normal range at 4.29–4.59 mIU/mL (normal
male range 4–25 mIU/mL) and 15.29–16.21 mIU/mL
(normal male value 7–24 mIU/ml), respectively.
Cytogenetic Analysis
Karyotype of all the 4 individuals with CAIS revealed
46,XY complement. None of the patients or family
members showed structural or numerical chromosomal
abnormality.
Histological
Hematoxylin-eosin–stained 4-mm paraffin sections of the
gonads showed widely dispersed seminiferous tubules
with thickened basement membrane. The tubules were
lined by about 3–5 layers of cells with elongated
cytoplasmic outlines and condensed darkly stained round
to oval nuclei. Some of the tubules showed occasionally
large flatter cells with large round nuclei having open
chromatin resembling spermatogonium, but no cell
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division could be seen in these cells. All other cells in
seminiferous tubules confirmed to Sertoli cell morpholo-
gy, which filled up the whole of the lumen of seminiferous
tubule. The size of the seminiferous tubule lumen was
comparatively smaller, giving the appearance of a highly
dense Sertoli cells population. The interstitial space was
filled with darkly stained eosinophilic granular cytoplasm
and single round nuclei, consistent with Leydig cells.
Overall, it appeared to be an immature testis, mostly with
Leydig cell hyperplasia (Figure 2).
DHPLC Analysis
DHPLC analysis indicated a mutation in exon 7 of the
AR gene of all the patients. Normal males (I-1, II-1, and
II-4) possessed wild-type allele (Figure 3A), individuals
with CAIS (II-3, II-5, II-6, and III-1) possessed mutant
allele (Figure 3B), and carrier females (I-2 and II-2)
showed heterozygous pattern (Figure 3C). Mixture of
amplicons of normal male (I-1) and individual with
CAIS (II-3) showed the same pattern as heterozygous
(Figure 3D).
Identification of the Mutation
Sequence analysis showed that all the patients had
C2578T hemizygous mutation in exon 7 of the AR gene
resulting in the replacement of leucine with phenylala-
nine (L859F) in the LBD of the receptor molecule. The
father (I-1), an apparently normal brother (II-4), and
individual II-1 had wild-type allele (C), whereas the
mother (I-2) and a fertile sister (II-2) possessed
heterozygous allele (C/T) at nucleotide position 3693
(Figure 1A). As is evident from Figure 1A, the mutation
was transmitted to the second and third generations in
similar fashion. The mutation was confirmed by
sequencing PCR products from 3 independent reactions
both in forward and reverse directions. Sequence
analysis of all other AR exons confirmed normal
sequence. None of the 100 control samples analyzed
showed mutation at this nucleotide position.
Discussion
The AR gene has been well studied in androgen
insensitivity and a number of mutations have been
reported, resulting in various grades of androgen
insensitivity in genetically male individuals. Although
Figure 2. Transverse section of the gonad of the proband. Gonadal section of the proband (II-3) showed hypoplastic testis containing widely
dispersed seminiferous tubules (1) with thick basement membrane (2) surrounded by fibroblasts (3). The interstitial space contains excess
number of Leydig cells (4), known as Leydig cell hyperplasia. The seminiferous tubules occasionally contain spermatogonium (5) but totally
filled with Sertoli cells (6).
Figure 3. Denaturing high-performance liquid chromatography
analysis of family with complete androgen insensitivity syndrome.
(A) Wild-type allele (I-1, II-1, and II-4 in Figure 1). (B) Mutant allele
(II-3, II-5, II-6, and III-1). (C) Heterozygous allele (I-2 and II-2).
(D) Mixture of wild and mutant alleles.
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several mutations have been reported in each exon of the
gene, most of the reported mutations associated with
AIS localize to LBD. All the reported mutations in the
AR gene are available at the androgen receptor
mutation database along with resulting phenotypes
(Gottlieb et al, 2004) (website: http://www.mcgill.ca/
androgendb).
Our present study on a familial case of CAIS revealed
a novel C2578T mutation leading to replacement of
leucine with phenylalanine at codon 859 (exon 7 of the
gene) of AR. Amino acid residue L859 is a part of LBD
of AR molecule. This residue is highly conserved, both
across species (Figure 4, upper panel) and in distantly
related receptors (members of steroid receptor super
family) such as progesterone receptor, estrogen receptor
alpha, retinoid X receptor alpha, and peroxisome
proliferator-activated receptor gamma (Figure 4, lower
panel).
The importance of this amino acid residue in the
functioning of the androgen receptor is further strength-
ened by 3-dimensional (3-D) architecture of the LBD.
Elucidation of 3-D crystallographic structure of AR-
LBD has established 12 a helices and 4 b strands
arranged in 2 b sheets, which make a typical helical
sandwich to form a ligand-binding pocket (Matias et al,
2000). The 12 helices of the AR protein are folded into
a 3-layered sandwich. Helices H1/2, H3, H7, and H10/11
form 2 outer layers, whereas inner layers consist of
a ligand-binding pocket and a non–ligand-binding
hydrophobic core (helices H4/5, H8, and H9). M807 in
the middle of H8 makes vanderwall interactions with
I799 and F794 in H7, L859, and L863 in H10 from outer
layers of sandwich and with adjacent F747 in H5 and
L838 in H9 of the hydrophobic core.
Furthermore, the atomic distances between residues
corresponding to M807 in H8 and L859 and L863 in
H10 in steroid receptor super family are similar and
highly conserved. The conservation of key residues and
atomic distances in H8 and H10 support that M807
(H8)-L859 (H10) interactions are critical for the stability
of holo-LBD (Ong et al, 2002). We suspect that
mutation of one of the key residues L859 in helix 10 in
the present case might be resulting in the disruption of
the critical interactions between these conserved resi-
dues. The ligand-binding pocket in the mutant receptor
is probably unable to attain proper conformation,
resulting in total disruption of ligand binding and hence
leading to the complete androgen insensitivity.
Similar to the L859F mutation in the present study,
most of the mutations falling in the a-helical and b sheet
regions of the receptor result in CAIS and those falling
in the ‘‘turns’’ and ‘‘linker’’ regions result in PAIS;
Figure 4. Multiple alignment of androgen receptor (AR) protein sequence. Multiple alignment of AR protein across species (upper panel) and
among steroid receptor super family members (lower panel) shows high conservation of L859 residue (highlighted by gray bar).
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however, a general correlation is difficult to derive
because some mutations in the helices and b sheet
regions cause PAIS and those in the turns and linker
regions cause CAIS (Yong et al, 1998). Interestingly, the
same mutation in different patients has been reported to
cause different levels of androgen insensitivity (Gottlieb
et al, 2004). G2445A mutation is known to cause both
PAIS and CAIS. More interestingly, C2296A mutation,
with proven pathogenicity in PAIS and CAIS patients,
was also found to be present in a totally normal person,
and G995A mutation known to cause MAIS, PAIS, and
CAIS has also been reported to exist in 8% of the
normal population (Gottlieb et al, 2004) (website: http://
www.androgendb.mcgill.ca/). In the present study,
sequencing of the exon 7 of the AR gene in 100 control
samples showed complete absence of this mutation in
the normal population.
In AIS patients, seminomas are the most common
type of testicular tumors. Very few reports are available
on adenomas and hyperplasia. Leydig cell hyperplasia
or tumors are rare tumors of male gonadal interstitium
that comprise approximately 3% of testicular neoplas-
mas. Rutgers and Scully (1991) reported the first case of
Leydig cell tumor in a patient with AIS. The present
study represents such a rare case of bilateral Leydig cell
hyperplasia. The patients underwent gonadectomy at
the ages of 18 years and 20 years. Generally, the risk of
developing testicular neoplasia is 3.6% by the age of
25 years and 33% by the age of 50 years. Given
hyperplasia at an age of 20 years, these patients were
highly likely to develop malignant tumors in the later
stages of life.
Despite many studies on AIS, it is still unclear what
exactly determines the type of gonadal cell undergoing
hyperplasia or tumor formation. Because many studies
refer to hyperplasia or tumor of only 1 gonad (Iwamoto
et al, 2005), another confounding issue is to decipher the
factors responsible for selective malignancy of 1
particular gonad in certain cases. It has been reported
that consistently high levels of LH result in Leydig cell
tumors formation (Fort et al, 1995). Surprisingly, in the
present case, Leydig cell hyperplasia developed despite
normal levels of LH. A better understanding of the
hormonal regulation of Sertoli and Leydig cell activity
and spermatogenesis will help in understanding the
correlation between the nature of AR gene mutation and
the type of cell undergoing hyperplasia or tumor
formation. Somatic mutations in the androgen target
tissues may be another factor affecting the preferential
hyper proliferation of certain types of testicular cells.
To conclude, the inheritance of the mutation through
generations in this family shows that the abnormality
could be attributed to the mutation reported here. It is
one of the rare cases of bilateral Leydig cell hyperplasia.
Our finding would be helpful in providing counseling to
this family and possibly helping them get a normal male
or female child by prenatal diagnosis, hence the trans-
mission of the mutated X chromosome to the coming
generations can be prevented.
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